What are Catalyst Pharmaceutical's profit margins?

Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.

Where do Catalyst Pharmaceutical's ratios come from?

Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Catalyst Pharmaceutical CPRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	85.2%-0.8pp	86%-1.0pp	86.9%+3.0pp	83.9%-0.5pp
Operating margin	43.8%+4.1pp	39.7%+17.9pp	21.8%-25.7pp	47.5%+10.3pp
Net margin	36.4%+3.1pp	33.3%+15.4pp	17.9%-20.9pp	38.8%+10.8pp
EBITDA margin	50.2%+2.8pp	47.4%+17.3pp	30.1%-17.8pp	47.9%+10.5pp
Free cash flow margin	35.4%-13.2pp	48.7%+12.7pp	36%—	——
Returns
Return on equity	25.5%-3.9pp	29.4%+8.6pp	20.7%-12.0pp	32.8%+11.8pp
Return on assets	21.9%-2.9pp	24.8%+7.9pp	16.9%-10.2pp	27.1%+8.7pp
Return on invested capital	84.5%+21.2pp	63.3%+12.8pp	50.5%-305pp	355.1%+256pp
Efficiency
Asset turnover	0.6×-0.1×	0.7×-0.2×	0.9×+0.2×	0.7×0.0×
Inventory turnover	3.1×-0.8×	3.9×-0.7×	4.6×-0.1×	4.7×+1.2×
Liquidity
Current ratio	6.1×+0.9×	5.2×+2.3×	2.9×-2.7×	5.6×-2.2×
Quick ratio	5.8×+0.8×	5×+2.3×	2.7×-2.8×	5.5×-2.0×
Cash ratio	4.8×+0.5×	4.3×+2.5×	1.8×-3.4×	5.2×-1.2×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.4×-0.2×	-2.2×-1.1×	-1.1×+1.8×	-2.9×+0.3×
Per Share
Book value per share	$7.50+28.8%	$5.82+70.8%	$3.41+26.4%	$2.70+40.6%
Valuation
Market capitalization	$2.87B+15.2%	$2.49B+38.9%	$1.79B-7.4%	$1.94B+177%
Enterprise value	$2.16B+9.5%	$1.97B+19.1%	$1.66B+1.0%	$1.64B+209%
Price / earnings	13.4×-1.8×	15.2×-9.9×	25.1×+1.8×	23.3×+5.6×
Price / sales	4.9×-0.2×	5.1×+0.6×	4.5×-4.5×	9×+4.1×
Price / book	3×-0.4×	3.4×-1.2×	4.6×-1.8×	6.4×+3.1×
EV / EBITDA	7.3×-1.2×	8.5×-5.4×	13.9×-2.2×	16×+5.9×
EV / sales	3.7×-0.3×	4×-0.1×	4.2×-3.5×	7.7×+3.9×
Free cash flow yield	7.3%-2.3pp	9.6%+1.6pp	8%—	——
Earnings yield	7.5%+0.9pp	6.6%+2.6pp	4%-0.3pp	4.3%-1.4pp
PEG ratio	0.4×+0.3×	0.1×—	——	0.2×—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Catalyst Pharmaceutical's profit margins?: Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.
Where do Catalyst Pharmaceutical's ratios come from?: Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.